Advertisement

Topics

Indian Immunologicals Limited Company Profile

18:30 EST 20th November 2018 | BioPortfolio

Indian Immunologicals Ltd (IIL) is a wholly owned subsidiary of National Dairy Development Board, established in 1983. IIL's plant at Hyderabad is built in collaboration with Wellcome Foundation of U.K. In addition to Foot and Mouth Disease (FMD) vaccine under the flagship brand name "Raksha", IIL also produces a range of other veterinary vaccines such as anti-rabies vaccine, Thileriosis vaccine, Bacterial vaccines, Canine vaccines and a host of other combined vaccines. These vaccines were added over the years through constant effort in our research and development. IIL has grown substantially from 1996 onwards and today, it is the No.1 Veterinary biologicals in the country. IIL also markets full range of Animal health products. IIL is credited with the launch of Nimovet inj for Veterinary use. Nimovet is the first Non-steroidal anti-inflammatory drug developed in the world in injectable form for veterinary use. IIL's plant at Hyderabad is one of the largest FMD vaccines producing plant in the world and certified with WHO-GMP and ISO 9001 certifications. IIL is also one among the largest exporters of Veterinary Biologicals in Asia.

Location

Road # 44, Jubilee Hills
Hyderabad
Andhra Pradesh
500033
India

Contact

Phone: 0091-40-55512428/23544585/23544593
Fax: 0091-40-23541786/23544007
Email: info@indimmune.com


News Articles [326 Associated News Articles listed on BioPortfolio]

Natatanuran frogs used the Indian Plate to step-stone disperse and radiate across the Indian Ocean

(Science China Press) The evolutionary history of near-cosmopolitan Natatanuran frogs involved using the Indian Plate as a stepping-stone to disperse between Africa, Asia and Madagascar. This research...

China opens market to Indian drugs with reduced tariffs

India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most populous countries. The agreement to reduce tariffs on Indian medicin...

NOW, MAKE IN UZBEKISTAN?

The Indian government's unending search for an alternative to end the over─dependence of Indian pharmaceutical companies on China for APIs has come a full circle as the Union Chemicals Ministry has ...

Indorama acquires PET plant in Egypt

Thai polyester giant Indorama Ventures (IVL) has entered a joint venture with India’s Dhunseri Petrochem to own and operate a 540,000 t/y PET production facility belonging to Egyptian Indian Pol...

Can you wash or reuse condoms? CDC says NO, warns people to use a ‘fresh one’ – The Indian Express

The Indian ExpressCan you wash or reuse condoms? CDC says NO, warns people to use a 'fresh one'The Indian ExpressIt is no secret that using a condom can have many health benefits. Not only does it pre...

Indian pharmaceutical patent prosecution: The changing role of Section 3(d)

This paper was originally published by Bhaven N. Sampat and Kenneth C. Shadlen in PLoS ONE 13(4): e0194714 under a Creative Commons license. Abstract India, like many developing countries, only recen...

Indian-Americans have fewer sudden infant deaths, Rutgers study finds

(Rutgers University) Indian-Americans have the highest percentage of sleeping with their babies among ethnic groups in New Jersey but the lowest rate of sudden unexpected infant death (SUID), a Rutger...

US FDA import alert and warning for Indian API maker

The US FDA has cited cleaning validation and electronic data access concerns in its warning letter to Indian API maker Reine Lifesciences.

Clinical Trials [202 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants

The purpose of this study is to assess the immunogenicity and safety of DTPa-IPV/Hib when administered at 6, 10 and 14 weeks to healthy Indian infants, as per guidance from the Indian regu...

A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population

This is a prospective, non-interventional, non comparative drug study. The efficacy of Quinapril in Asian population has been evaluated, but specifically in Indian patients the data is spa...

Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis

This is an active surveillance study to monitor the real world safety of nintedanib in Indian patients with Idiopathic Pulmonary Fibrosis. The safety of nintedanib has been assessed in cli...

Polarity Therapy for American Indian Caregivers of Dementia Patients

The purpose of this study is to assess the effectiveness of polarity therapy (PT), a complementary and alternative medicine treatment, in American Indian caregivers living in the Pacific N...

Reducing Diabetes Risk Factors in American Indian Children: Tribal Turning Point

This study will evaluate a behavioral intervention designed to reduce risk factors for type 2 diabetes in American Indian youth aged 7-10 years.

Companies [175 Associated Companies listed on BioPortfolio]

Indian Immunologicals Limited

Indian Immunologicals Ltd (IIL) is a wholly owned subsidiary of National Dairy Development Board, established in 1983. IIL's plant at Hyderabad is built in collaboration with Wellcome Foundation of U....

American Indian College Fund

With its credo "Educating the Mind and Spirit," the American Indian College Fund is the nation's largest provider of private scholarships for American Indian students, providing an average of 6,000 sc...

XANSA UK LIMITED

Xansa is an outsourcing and technology company.Committed to delivering guaranteed business outcomes through a combination of technology and process expertise, we give our clients the freedom to do mor...

The Indian Journal of Pharmacology

The Indian Journal of Pharmacology (ISSN 0253-7613) is an official organ of the Indian Pharmacological Society. The first issue of the journal came out in 1969 and it was published quarterly. In 1997 ...

Eros International Plc

Eros International Plc (NYSE: EROS) is a leading global company in the Indian film entertainment industry that acquires, co-produces and distributes Indian films across all availa...

More Information about "Indian Immunologicals Limited" on BioPortfolio

We have published hundreds of Indian Immunologicals Limited news stories on BioPortfolio along with dozens of Indian Immunologicals Limited Clinical Trials and PubMed Articles about Indian Immunologicals Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Indian Immunologicals Limited Companies in our database. You can also find out about relevant Indian Immunologicals Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record